US Food and Drug Administration Expanded Adjuvant Indication of Abemaciclib in High-Risk Early Breast Cancer.

Melanie Royce,Flora Mulkey,Christy Osgood,Erik Bloomquist,Laleh Amiri-Kordestani

Journal of clinical oncology : official journal of the American Society of Clinical Oncology（2023）

Cited 2|Views19
No score
Key words
abemaciclib,breast cancer,adjuvant indication,high-risk
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined